Insights - SPAC and ESG Research from Boardroom Alpha

Activism, Governance, & Executive Moves

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

SPAC Analysis

Comera Life Sciences Debuts in the Red

May 20, 2022 | SPACs

Comera Life Sciences (CMRA), the maker of self-injectible biologics, deSPAC’d today, closing down 9%. An updated look at deSPAC count and redemption rates. And the rest of the day’s news in SPACs.

SPAC Deals on a Daily Double

May 19, 2022 | SPACs

Another 2 SPAC DAs today, offset by some liquidations. And the rest of the day’s news in SPACs.

MSP Recovery Approved Amidst Market Bloodbath

May 18, 2022 | SPACs

Amidst the ongoing market bloodbath, SPACs continue to march forward. LCAP gets approval for MSP Recovery. And the rest of the day’s news in SPACs.

2 More DAs as the Market Bounces Back Today

May 17, 2022 | SPACs

As the market bounces back today, 2 more DAs in virtual reality and propTech. And the rest of the day’s news in SPACs.

Research & Analysis

Driven by the Boardroom Alpha Platform